Problem statement: Answer the multiple-choice question.
Question: Which drug has a -20.228% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a. Cc1cccc(CC(=O)NCCS(=O)(=O)N2CCN(c3cccc(Cl)c3)CC2)c1
b. O=C(c1cccc(S(=O)(=O)N2CCN(c3ccc(F)cc3)CC2)c1)N1CCCC(C(F)(F)F)C1
c. CC(NCC(O)COc1ccc2ccccc2c1)c1ccccc1.O=C(O)C(=O)O
d. CS(=O)(=O)c1ccc(Cl)c(NC(=O)C2CCCCN2S(=O)(=O)c2ccccc2)c1
Answer: a. Cc1cccc(CC(=O)NCCS(=O)(=O)N2CCN(c3cccc(Cl)c3)CC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccc(CC(=O)NCCS(=O)(=O)N2CCN(c3cccc(Cl)c3)CC2)c1
Cc1cccc(CC(=O)NCCS(=O)(=O)N2CCN(c3cccc(Cl)c3)CC2)c1
N-[2-[4-(3-chlorophenyl)piperazin-1-yl]sulfonylethyl]-2-(3-methylphenyl)acetamide